Sucampo Pharma (SCMP) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Income (loss) before income taxes: 15.5M
Today's EPS Names:
OMID, SICP, SCKT, More
Financial Fact:
Income (loss) before income taxes: 15.5M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Sucampo Pharma (NASDAQ: SCMP) reported Q1 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $44.11 million.
GUIDANCE:
Sucampo Pharma sees FY2016 EPS of $0.97-$1.07, versus the consensus of $1.05. Sucampo Pharma sees FY2016 revenue of $195-205 million, versus the consensus of $202.3 million.
For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
